BR0304956A - Pharmaceutical combination in a new pharmaceutical form useful in hypertension and chronic stable coronary insufficiency - Google Patents

Pharmaceutical combination in a new pharmaceutical form useful in hypertension and chronic stable coronary insufficiency

Info

Publication number
BR0304956A
BR0304956A BR0304956-6A BR0304956A BR0304956A BR 0304956 A BR0304956 A BR 0304956A BR 0304956 A BR0304956 A BR 0304956A BR 0304956 A BR0304956 A BR 0304956A
Authority
BR
Brazil
Prior art keywords
hypertension
coronary insufficiency
form useful
chronic stable
stable coronary
Prior art date
Application number
BR0304956-6A
Other languages
Portuguese (pt)
Inventor
Omilton Visconde Jr
Original Assignee
Laboratorios Biosintetica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Biosintetica Ltda filed Critical Laboratorios Biosintetica Ltda
Priority to BR0304956-6A priority Critical patent/BR0304956A/en
Priority to ECSP045478 priority patent/ECSP045478A/en
Priority to MXPA04012380 priority patent/MXPA04012380A/en
Priority to ARP040104581 priority patent/AR046876A1/en
Priority to PE2004001213A priority patent/PE20050901A1/en
Priority to CO04123478A priority patent/CO5650066A1/en
Publication of BR0304956A publication Critical patent/BR0304956A/en

Links

Abstract

"COMBINAçãO FARMACêUTICA EM UMA NOVA FORMA FARMACêUTICA úTIL NA HIPERTENSãO ARTERIAL E NA INSUFICIêNCIA CORONARIANA CRÈNICA ESTáVEL".~ A presente invenção propõe a associação farmacêutica estável entre um betabloqueador na forma de granulado e um antagonista dos canais de cálcio pertencente à classe dos dihidropiridínicos na forma de comprimido, os quais são envolvidos por uma cápsula de gelatina dura."PHARMACEUTICAL COMBINATION IN A NEW USEFUL PHARMACEUTICAL FORM IN ARTERIAL HYPERTENSION AND STABLE CHRONIC CORONARY INSUFFICIENCY." tablets, which are surrounded by a hard gelatin capsule.

BR0304956-6A 2003-12-09 2003-12-09 Pharmaceutical combination in a new pharmaceutical form useful in hypertension and chronic stable coronary insufficiency BR0304956A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
BR0304956-6A BR0304956A (en) 2003-12-09 2003-12-09 Pharmaceutical combination in a new pharmaceutical form useful in hypertension and chronic stable coronary insufficiency
ECSP045478 ECSP045478A (en) 2003-12-09 2004-12-08 PHARMACEUTICAL COMBINATION IN A NEW USEFUL PHARMACEUTICAL FORM IN ARTERIAL HYPERTENSION AND IN STABLE CORONARY INSUFFICIENCY.
MXPA04012380 MXPA04012380A (en) 2003-12-09 2004-12-09 Pharmaceutical combination in a novel pharmaceutical form useful for treating arterial hypertension and stable chronic coronary-artery insufficiency.
ARP040104581 AR046876A1 (en) 2003-12-09 2004-12-09 PHARMACEUTICAL ASSOCIATION IN A USEFUL PHARMACEUTICAL FORM IN ARTERIAL HYPERTENSION AND IN STABLE CHRONIC CORONARY INSUFFICIENCY
PE2004001213A PE20050901A1 (en) 2003-12-09 2004-12-09 COMBINATION OF AMLODIPINE AND ATENOLOL IN THE PHARMACEUTICAL FORM OF CAPSULE
CO04123478A CO5650066A1 (en) 2003-12-09 2004-12-09 PHARMACEUTICAL COMBINATION IN A NEW USEFUL PHARMACEUTICAL FORM IN ARTERIAL HYPERTENSION AND IN STABLE CORONARY INSUFFICIENCY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0304956-6A BR0304956A (en) 2003-12-09 2003-12-09 Pharmaceutical combination in a new pharmaceutical form useful in hypertension and chronic stable coronary insufficiency

Publications (1)

Publication Number Publication Date
BR0304956A true BR0304956A (en) 2005-11-08

Family

ID=35295191

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0304956-6A BR0304956A (en) 2003-12-09 2003-12-09 Pharmaceutical combination in a new pharmaceutical form useful in hypertension and chronic stable coronary insufficiency

Country Status (6)

Country Link
AR (1) AR046876A1 (en)
BR (1) BR0304956A (en)
CO (1) CO5650066A1 (en)
EC (1) ECSP045478A (en)
MX (1) MXPA04012380A (en)
PE (1) PE20050901A1 (en)

Also Published As

Publication number Publication date
CO5650066A1 (en) 2006-06-30
PE20050901A1 (en) 2005-12-16
MXPA04012380A (en) 2005-10-19
ECSP045478A (en) 2006-09-18
AR046876A1 (en) 2005-12-28

Similar Documents

Publication Publication Date Title
NO20052739D0 (en) CCR5 antagonists as drugs
ATE485835T1 (en) PHARMACEUTICAL SOLUTIONS CONTAINING ANTIBODIES
AR047841A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF IMMUNE-INFLAMMATORY DISORDERS
ATE223719T1 (en) FAST DISSOLVING EFAVIRENZ CAPSULES OR TABLETS BY USING SUPER DECOMPOSITORS
BRPI0513379A (en) sulfonamide derivatives
DE60312049D1 (en) STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING AN AMORPHANT AGENT
EA200401515A1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERIN IN POLYMORPHIC MODIFICATION A
ATE367152T1 (en) PRODUCTION METHOD FOR LOW DOSE PHARMACEUTICAL COMPOSITION
ATE490273T1 (en) GELATIN CAPSULES
DK1694311T3 (en) Chewable soft capsules containing ungelatinized starch
DE60021609D1 (en) A pharmaceutical composition containing a metabolite of buspirone
BR0304956A (en) Pharmaceutical combination in a new pharmaceutical form useful in hypertension and chronic stable coronary insufficiency
ATE332690T1 (en) ORAL DISPERSION PHARMACEUTICAL COMPOSITION CONTAINING PERINDOPRIL
FR2870539B1 (en) NEW METHODS AND MEDICINES
BR0312875A (en) Film-Resistant Gelatin Capsule
ATE489943T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING 2,3-DIHYDRO-6-NITROIMIDAZOÄ2,1-BUOXAZOLE DERIVATIVES
FR2842621B3 (en) COMPUTER MOUSE PACKAGE
IS7581A (en) A pharmaceutical composition
DK1750765T3 (en) Pharmaceutical antimycobacterial composition comprising an antituberculous drug
DE60217369D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GAMMA BUTYROBETAIN
TW200500376A (en) Novel adenosine analogues and their use as pharmaceutical agents
Pierin Hipertensão arterial
BRPI0515727A (en) biomarker for heart failure
BRPI0415428A (en) therapeutic formulations
UY27824A1 (en) NEW FORMULATION FOR THE PARENTERAL ADMINISTRATION OF CROBENETINE.

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: BASEADO NO ART. 216 1 DA LPI, APRESENTE COPIA AUTENTICADA DA PROCURACAO PARA QUE ESTA SEJA ACEITA.

B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: BIOSINTETICA FARMACEUTICA LTDA (BR/SP)

Free format text: ALTERADO DE: LABORATORIOS BIOSINTETICA LTDA

B25G Requested change of headquarter approved

Owner name: BIOSINTETICA FARMACEUTICA LTDA (BR/SP)

Free format text: ALTERADA A SEDE DO TITULAR CONFORME REQUERIDO NA PETICAO NO 018050004541/SP DE 18/07/2005.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25M Entry on limitation or onus of patent assignment [chapter 25.13 patent gazette]

Owner name: BIOSINTETICA FARMACEUTICA LTDA (BR/SP)

Free format text: REF: PROC. INPI NO 52400031036/2012-78 E PROCESSO DE ARROLAMENTO DE BENS DA SECRETARIA DA RECEITA FEDERAL SP NO 16643.720002/2011-54 ANOTADO O ARROLAMENTO DO PEDIDO DE PATENTE EM EPIGRAFE, CONFORME DETERMINACAO DA SECRETARIA DA RECEITA FEDERAL DO ESTADO DE SAO PAULO, NOS TERMOS DO 5O, DO ART. 64 DA LEI NO 9.532/97.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 9A E 10A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2257 DE 08/04/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 9A, 10A, 11A, 12A, 13A, 14A, 15A E 16A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.